[Evaluation of efficacy and tolerability of ioversol in intravenous urography].
In an open clinical trial, 100 patients have been injected with ioversol (Optiray 350) during an IVP performed for various indications. This low osmolality contrast medium, which is remarkably hydrophilic, has exhibited a safety of use and image quality which were quite satisfactory.
Lemaître
L
L
Service de Radiologie Ouest, Hôpital Huriez, CHR, Lille.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002137:Calculi / Q000000981:diagnostic imaging; D003287:Contrast Media; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011469:Prostatic Diseases / Q000000981:diagnostic imaging; D014283:Triiodobenzoic Acids / Q000008:administration & dosage / Q000009:adverse effects; D014552:Urinary Tract Infections / Q000000981:diagnostic imaging; D014567:Urography / Q000379:methods*; D014571:Urologic Neoplasms / Q000000981:diagnostic imaging
D003287:Contrast Media; D014283:Triiodobenzoic Acids; C054871:ioversol
Evaluation de l'efficacité et de la tolérance du ioversol en urographie intraveineuse.